USPTO serial 97119663
GATOR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 4, 2023
- Examiner
- DIBLE, JONATHON I
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with GATOR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Viola T. Kung
Viola T. Kung PERKINS COIE LLPP.O. BOX 2608SEATTLE, WA 98111UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations other than for medical or veterinary purposes, namely, reagents, buffers, and preparations for reacting with biomolecules; chemical preparations other than for medical or veterinary purposes, namely, reagents, buffers, and preparations for altering the nature of a probe to which biomolecules bind over the course of a procedure; chemical preparations other than for medical or veterinary purposes, namely, reagents, buffers, and preparations for modifying a probe to which biomolecules bind for diagnostic purposes; reagents for scientific use; reagents for research use; biochemical reagents for non-medical purposes, namely, for detecting and analyzing molecules in arrays; laboratory chemicals, namely, reagents used to detect antigens or antibodies in liquid samples for in vitro diagnostic use; interference assays for research use | ACTIVE | May 29, 2018 |
| 005 | Diagnostic preparations for medical or veterinary purposes, namely, reagents, buffers, and preparations for reacting with biomolecules; diagnostic preparations for medical or veterinary purposes, namely, reagents, buffers, and preparations for modifying a probe to which biomolecules bind for diagnostic purposes; reagents for medical use; reagents for medical diagnostic use; biochemical reagents for medical purposes, namely, for detecting and analyzing molecules in arrays; laboratory chemicals, namely, medical diagnostic reagents used to detect antigens or antibodies in liquid samples for medical purposes; medical diagnostic reagents for testing of body fluids; medical diagnostic reagents for detecting biomarkers for medical or veterinary purposes | ACTIVE | May 29, 2018 |
| 009 | Optical instruments for measuring a reaction by monitoring changes in the reflection of light, namely, interferometers; imaging instruments for use in the study of biomolecules, including proteins, ligands, and nucleic acids, for research purposes; imaging instruments for measuring binding of molecules to determine antibody affinity to an antigen for research purposes; imaging instruments for measuring binding of molecules to determine receptor-ligand binding for research purposes; laboratory instruments in the nature of interferometers for use in collecting real-time measurements to support the analysis of biological molecules at different stages of therapeutic development, not for medical use; probes for scientific, research, or diagnostic testing purposes, not for medical use; laboratory instruments in the nature of surface plasmon resonance (SPR) tools for label-free analysis of biomolecules for scientific, research, or diagnostic testing purposes, not for medical use; probes for scientific, research, or diagnostic testing purposes, not for medical use, namely, probes to which biomolecules bind over the course of a scientific, research, or diagnostic testing procedure; probes for scientific, research, or diagnostic testing purposes, not for medical use, namely, probes to which biomolecules bind while performing polymerase chain reaction (PCR) as part of a scientific, research, or diagnostic testing procedure; probes for scientific, research, or diagnostic testing purposes, not for medical use, namely, probes to which biomolecules bind while performing genetic sequencing as part of a scientific, research, or diagnostic testing procedure; probes for scientific, research, or diagnostic testing purposes, not for medical use, namely, probes to which biomolecules bind while performing an enzyme-linked immunosorbent assay (ELISA) as part of a scientific, research, or diagnostic testing procedure; interferometric sensors in the nature or interferometers; interferometric instruments in the nature or interferometers for use in scientific, research, or diagnostic procedures; fluorescent sensors for scientific use; fluorescent instruments for use in scientific, research, or diagnostic testing procedures, not for medical use, in the nature of fluorescent sensors; chemiluminescent sensors for scientific use; chemiluminescent instruments for use in scientific, research, or diagnostic testing procedures, not for medical use, in the nature of chemiluminescent sensors; optical instruments for scientific use, namely, biomolecular interferometry (BLI) instruments for analyzing biomolecules in samples without using fluorescent markers | ACTIVE | May 29, 2018 |
| 010 | Medical diagnostic instruments for measuring a reaction by monitoring changes in the reflection of light, namely, interferometers; imaging instruments for use in the study of biomolecules, including proteins, ligands, and nucleic acids, for medical purposes; imaging instruments for measuring binding of molecules to determine antibody affinity to an antigen for medical purposes; imaging instruments for measuring binding of molecules to determine receptor-ligand binding for medical purposes; probes for medical diagnostic purposes; laboratory instruments in the nature of surface plasmon resonance (SPR) measuring apparatus for label-free analysis of biomolecules for medical diagnostic purposes; probes for medical purposes, namely, probes to which biomolecules bind over the course of a medical diagnostic procedure; probes for medical purposes, namely, probes to which biomolecules bind while performing polymerase chain reaction (PCR) as part of a medical diagnostic procedure; probes for medical purposes, namely, probes to which biomolecules bind while performing genetic sequencing as part of a medical diagnostic procedure; probes for medical purposes, namely, probes to which biomolecules bind while performing an enzyme-linked immunosorbent assay (ELISA) as part of a medical diagnostic procedure; interferometric sensors in the nature or interferometers for medical use; interferometric instruments in the nature or interferometers for use in medical diagnostic procedures; fluorescent sensors for medical use; fluorescent instruments for use in medical diagnostic procedures in the nature of fluorescent sensors; chemiluminescent sensors for medical use; chemiluminescent instruments for use in medical diagnostic procedures in the nature of chemiluminescent sensors; medical diagnostic instruments, namely, biomolecular interferometry (BLI) instruments for analyzing biomolecules in samples without using fluorescent markers | ACTIVE | May 29, 2018 |
| 042 | Scientific research services, namely, measurement and analysis of interactions between biomolecules; scientific and clinical medical research in the field of biomolecules; scientific and clinical medical research in the field of interferometric sensors, fluorescent sensors, and chemiluminescent sensors; biological research; biochemical research; research and development services in the field of reagents; research and development services in the fields of interferometric sensors, fluorescent sensors, and chemiluminescent sensors; research and development services in the field of medical diagnostic instruments; research and development services in the field of biolayer interferometry (BLI); research and development services in the field of biosensors operable to monitor biomolecular interactions through interferometry | ACTIVE | May 29, 2018 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Probe Life, Inc.
- Other trademarks owned by Probe Life, Inc.
- Other trademarks owned by Probe Life, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named GATOR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 4, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 4, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 18, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 18, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 29, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 15, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 15, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 14, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 14, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 14, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 23, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 19, 2021 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Nov 18, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 15, 2021 | NWAP | NEW APPLICATION ENTERED | — |